CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nordion Inc(USA) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nordion Inc(USA)
447 March Rd.
Phone: (613) 592-2790p:613 592-2790 OTTAWA, ON  K2K 1X8  Canada Ticker: NDZNDZ

This company was Merged or Acquired on 8/6/2014.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Nordion Inc. (Nordion), is a global health science company. The Company is engaged in products and services used for the prevention, diagnosis and treatment of disease. The Company operates one business unit, Specialty Isotopes. It operates in two segments: Sterilization Technologies and Medical Isotopes. On July 13, 2013, Nordion completed the sale of its Targeted Therapies business to BTG, an international specialist healthcare company based in London, United Kingdom. In August 2014, the Company announced that it has completed the plan of arrangement and all of the outstanding common shares of Nordion Inc have been acquired by an affiliate of Sterigenics International LLC. Effective August 6, 2014, Sterigenics International Inc, a unit of GTCR LLC, acquired the entire share capital of Nordion Inc.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
4/30/201410/31/2013YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board William D.Anderson 65 1/1/2010 2/2/2007
President, Chief Executive Officer, Non-Independent Director Steven M.West 61 1/8/2010 4/1/2003
Chief Financial Officer G. PeterDans 2/1/2010 1/1/2007
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 411 (As of 10/31/2013)
Outstanding Shares: 61,909,301 (As of 4/30/2014)
Shareholders: 710
Stock Exchange: NYSE
Fax Number: (613) 592-6937
Email Address: InvestorRelations@mdsintl.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023